MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/09546634.2019.1673877

Медицинская библиотека · The Journal of dermatological treatment · 2019

Off-label studies on tofacitinib in dermatology: a review.

Tegtmeyer Kyle, Zhao Jeffrey, Maloney Nolan J, Atassi Giancarlo, Beestrum Molly, Lio Peter A

СтатьяОбзорПеревод в очереди

Аннотация

PURPOSE: Tofacitinib citrate is an oral Janus kinase 1/3 inhibitor approved for rheumatoid arthritis, ulcerative colitis, and active psoriatic arthritis. Tofacitinib is being increasingly used off-label for dermatological conditions, with varying efficacy across recent studies. A review of these studies will be a helpful resource for dermatologists considering the use of tofacitinib for conditions refractory to first-line therapies.

MATERIALS AND

METHODS

MEDLINE, Embase, CINAHL Plus, Cochrane Library, Scopus, Web of Science, Clinicaltrials.gov, and the WHO International Clinical Trials Registry Platform were all searched for articles and trials mentioning the term 'tofacitinib', then manually reviewed to identify published data on off-label uses of tofacitinib. The article was structured according to the quality of the evidence available.

RESULTS

Tofacitinib appears to show strong efficacy for numerous dermatologic conditions. Randomized controlled trial data is available for atopic dermatitis, alopecia areata, and plaque psoriasis. Case report and case series data is available for numerous other dermatologic conditions.

CONCLUSION

While tofacitinib has a wide array of immunoregulatory properties, making it a possible candidate for treating many dermatologic conditions refractory to other treatments, further testing is needed to better characterize its efficacy and utility moving forward, as well as its safety and adverse effect profile.

Для цитирования: Tegtmeyer Kyle, Zhao Jeffrey, Maloney Nolan J, Atassi Giancarlo, Beestrum Molly, Lio Peter A. Off-label studies on tofacitinib in dermatology: a review.. The Journal of dermatological treatment. 2019. DOI: 10.1080/09546634.2019.1673877.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.